Search for Bristol-Myers Squibb Co and
    1. July 28, 2015

      Clinical trial data should be open to public view

      A much needed drive to open the results of clinical trials to public scrutiny is gathering momentum. Last week 85...

    2. July 12, 2015

      Drugmakers premiere summer blockbusters

      Blockbuster drugs are back. A wave of new multibillion-dollar medicines for heart disease and high cholesterol, added...

    Special Reports

    1. Corporate Longevity

      The FT launches a global investigation into the mixture of innovation and focus that c...
    2. Combating Cancer

      A wave of drugs that harnesses the body’s immune system is fuelling optimism that scie...
    Search more Special Reports on this topic.

    1. June 5, 2015

      Cancer treatment: Healing powers

      It felt more like a gathering of Silicon Valley entrepreneurs than a mainstream medical meeting. But the 30,000...

    2. May 31, 2015

      Clinical trials show cancer drug combo boosts survival rate

      A combination of two “immunotherapy” medicines made by Bristol-Myers Squibb can dramatically improve the chances of...

    3. May 29, 2015

      Doctors hail new front in fight against cancer

      A novel class of drugs that turn the body into a weapon against tumours are set to be given to 60,000 of the sickest...

    4. May 29, 2015

      Novel cancer drugs tipped to boost drug sales

      In 1947, Sidney Farber, a pathologist working in a tiny hospital laboratory in Boston, gave an experimental cocktail of...

    5. May 15, 2015

      The drugs to watch in fight against cancer

      About 30,000 doctors and scientists will arrive in Chicago in two weeks for the annual meeting of the American Society...

    6. April 20, 2015

      Bristol-Myers combination melanoma treatment shows promise

      Skin cancer patients taking two Bristol-Myers Squibb drugs that help their immune systems fight melanoma saw their...

    7. April 13, 2015

      Biotech: Making sense of the science

      It was supposed to be a wonder drug. Provenge promised to turn the body’s immune system into a weapon against disease,...

    8. April 7, 2015

      Big pharma turns to small biotechs for edge in cancer treatment

      Partnerships between big pharma and small biotech companies have highlighted the scramble for assets in a new category...

    9. April 6, 2015

      US stock rise defies disappointing jobs data

      US stocks confounded expectations to push higher on Monday in their first trading session following last week’s...

    10. February 2, 2015

      Big pharmaceuticals groups faces biosimilars challenge

      Global pharmaceuticals companies have seen an improvement in their drugs pipelines but the industry is facing a fresh...

    11. January 15, 2015

      Healthcare: Counting the cost of cancer

      Anne Strange was too ill to dance at the evening reception when her daughter, Debbie, married in November but just...

    12. December 17, 2014

      Juno Therapeutics vies for cancer treatment lead

      When Juno Therapeutics lists on Nasdaq on Friday, it will be one of the biggest events in a big year for the buoyant US...

    13. December 8, 2014

      US sues Deutsche in $190m taxes claim

      Deutsche Bank and other firms are being pursued for more than $190m over allegedly setting up shell companies to avoid...

    14. December 1, 2014

      ‘Milestone’ in fight against Aids as treatment outpaces infections

      The world has passed an important tipping point in the fight against Aids, according to data showing that more people...

    15. September 26, 2014

      Drug development: Big pharma back in the game it made

      Big pharma is back. That, at least, is the impression created by a wave of new cancer drugs rapidly approaching market....

    16. September 26, 2014

      Battling cancer: Focus turns to defence as best form of attack

      It has been described as the beginning of the end of cancer. A new wave of drugs that harnesses the body’s immune...

    17. August 4, 2014

      Bristol-Myers Squibb in venture to turn US research into drugs

      Allied Minds, a Boston-based science and technology development company, has joined forces with biopharmaceutical giant...

    18. July 31, 2014

      Drug pricing: Bitter pill

      When delegates turned up for a big healthcare conference at New York’s plush Waldorf Astoria hotel in February, they...

    19. July 27, 2014

      Hepatitis C researchers battle to ‘nuke’ the competition

      Idenix has fewer than 100 employees and no products on the market. So what was it that persuaded Merck to pay $3.85bn –...

    20. July 16, 2014

      Eli Lilly joins forces with UK biotech to develop cancer drugs

      Eli Lilly has entered the race to develop a new generation of oncology drugs, which harness the immune system to kill...

    21. June 29, 2014

      Green chemistry: Pharmaceutical companies try to clean up their act

      Pharmaceutical companies tend to highlight their role in saving lives, but say little about the impact their...

    22. June 10, 2014

      Hepatitis C: Gilead’s Odyssey

      The Hepatitis C virus is the kind of problem that drug companies are meant to solve. The World Health Organisation...

    23. May 30, 2014

      Hopes for cancer cures offer comfort for battered pharma

      It is the Holy Grail of medical science. Ever since Hippocrates, the Greek physician, first described the disease more...

    24. FT Alphaville

      May 6, 2014

      About that AstraZeneca bid defence ...

      The nationalistic bluster around AstraPfizica remains blustery. Here, for example, is London Mayor Boris Johnson: It...

    25. April 13, 2014

      Drug groups step up race for hepatitis C treatments

      Drugmakers are stepping up the race for multibillion-dollar hepatitis C treatments after trial data showed how the...

    26. April 1, 2014

      Bristol-Myers Squibb: side effects

      One of these things is not like the others, as Big Bird sings. Look at the mega-cap pharma and biotech stocks. In the...

    27. January 27, 2014

      Hepatitis C: Treated – at a price

      Gemma Peppe lived with hepatitis C for two decades before she – and the teenage son she inadvertently infected at birth...

    28. FT Alphaville

      December 19, 2013

      The (early) Lunch Wrap

      Good morning New York, FT ALPHAVILLE Izzy continues to expand her theory of money entanglement, a look at the...

    29. December 19, 2013

      AstraZeneca in $4bn buyout of diabetes venture partner

      AstraZeneca is to buy out its joint venture with Bristol-Myers Squibb in a deal worth up to $4.3bn, as it seeks to...

    30. November 8, 2013

      Bristol-Myers Squibb could realise $6bn from diabetes franchise

      Bristol-Myers Squibb could generate up to $6bn from the sale of its diabetes franchise, according to an analyst’s...

    31. FT Alphaville

      October 24, 2013

      Does this stock need medicating?

      It’s Shire, of course, reacting to a warning of better than expected earnings. The stock was up 8.7 per cent at 2744p...

    32. September 16, 2013

      S&P 500 breaks back above 1,700

      The S&P 500 broke back above the 1,700 level in intraday trading on Monday as US equities rallied and bond yields fell...

    33. August 25, 2013

      Amgen’s $10.5bn takeover of Onyx approved by both boards

      Amgen said on Sunday night that its takeover of Onyx, the US cancer drug developer, at $125 a share had been approved...

    34. June 10, 2013

      Markets Insight: The Fed has turned markets upside down

      Stellar performance across most asset classes has been the norm until recently. Equity markets are up sizeably and, in...

    35. June 3, 2013

      Carmakers help fuel US stocks

      Auto companies were in focus on the first trading day of June, as the S&P 500 recovered from morning losses to finish...

    36. May 22, 2013

      US stocks step back from intraday highs

      An afternoon sell-off knocked US stocks back from intraday record highs as investors weighed the Federal Reserve’s...

    37. April 29, 2013

      US pharma: spot the difference

      The big US drug companies look eerily alike. Pfizer, Merck, Eli Lilly and AbbVie (formerly Abbott) are all expanding...

    38. beyondbrics

      April 17, 2013

      Big Pharma says Olá to Brazil

      By Pan Kwan Yuk and Thalita Carrico Brazil’s burgeoning middle class might have helped propel the country to the top of...

    Search for Bristol-Myers Squibb Co and